Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 28 January 2022)


Open article in different language:  DE  |  FR  |  IT
Art. 13 Market release

1 The Re­spons­ible Per­son em­ployed by the hold­er of the mar­ket­ing au­thor­isa­tion de­cides on the mar­ket re­lease of a batch be­fore it is placed on the mar­ket.

2 They check wheth­er:

a.
a val­id batch cer­ti­fic­ate is­sued by the man­u­fac­turer is avail­able and wheth­er the batch was man­u­fac­tured in con­form­ity with the GMP rules de­scribed in An­nex 1;
b.
the batch in ques­tion ful­fils the re­quire­ments of the au­thor­isa­tion;
c.
the con­di­tions de­scribed in Art­icles 11 and 12 have been ful­filled; and
d.
the en­tire sup­ply chain is in con­form­ity with the au­thor­isa­tion and the GDP5 rules de­scribed in An­nex 4.

3 Swiss­med­ic may spe­cify ad­di­tion­al checks.

4 The Re­spons­ible Per­son con­firms that the checks de­scribed in para­graphs 2 and 3 have been per­formed.

5 Stands for: Good Dis­tri­bu­tion Prac­tice

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden